a biotechnology company, which develops innovative adult stem cell therapeutic products
Industry Biotechnology
A.I.dvisor tells us that BCLI and ADCT have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BCLI and ADCT's prices will move in lockstep.
Ticker / NAME | Correlation To BCLI | 1D Price Change % | ||
---|---|---|---|---|
BCLI | 100% | -3.42% | ||
ADCT - BCLI | 28% Poorly correlated | -6.03% | ||
ATHE - BCLI | 27% Poorly correlated | -0.85% | ||
LABFF - BCLI | 26% Poorly correlated | N/A | ||
TBPH - BCLI | 24% Poorly correlated | -1.14% | ||
MTNB - BCLI | 24% Poorly correlated | -10.65% | ||
More |
Ticker / NAME | Correlation To BCLI | 1D Price Change % |
---|---|---|
BCLI | 100% | -3.42% |
therapeutics theme (53 stocks) | 17% Poorly correlated | -2.40% |
computers theme (126 stocks) | 16% Poorly correlated | -1.25% |
stem cells theme (21 stocks) | 13% Poorly correlated | -3.36% |
biotechnology theme (238 stocks) | 6% Poorly correlated | -1.76% |